Medicenna Therapeutics

-$0.03 (-0.87%) As of 5:31 PM UTC today

Why Robinhood?

You can buy or sell MDNA and other stocks, options, and ETFs commission-free!

About MDNA

Medicenna Therapeutics Corp. Common Shares, also called Medicenna Therapeutics, is a clinical stage immuno-oncology company which engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers.

CEO
Fahar Merchant
Employees
7
Headquarters
Toronto, Ontario
Founded
2015

MDNA Key Statistics

Market Cap
186.99M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
322.52K
High Today
$3.48
Low Today
$3.33
Open Price
$3.37
Volume
51.49K
52 Week High
$6.84
52 Week Low
$3.02

MDNA Earnings

-$0.11
-$0.07
-$0.04
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected May 25, Pre-Market

You May Also Like

PMGMW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure